Abstract:Background Demonstrated the great potential of facilitating bone regeneration, bone morphogenetic protein-2 (BMP-2) derived synthetic oligopeptide (S[PO4] KIPKASSVPTELSAISTLYLDDD, P24) has exhibited good osteoinductive and ectopic bone formation features. However, the defect of alveolar is always with irregular shapes and the bone formation is a long process, hence the application of P24 requires sustained release at certain concentration in irregular defects throughout the process of bone regeneration. Aim/Hypothesis We hypothesized that this P24-loaded hydrogel system could modulate osteogenic differentiation and hydrogel mineralization in vitro. After implanted in a rat critical size cranial defect, the composite hydrogels would be hypothesized to enhance bone regeneration. Materials and Methods PLGA-P24 microspheres were prepared with water-in-oil-in-water double emulsion. 10% nano hydroxyapatite (n-HA) and 5% PLGA-P24 microspheres were dispersed in 4% aldehyde dextran solution. Then composite hydrogel (CD n-HA PLGA-P24) was prepared via adding 0.5 ml mixture solution into 0.5 ml 4% hydroxypropyl chitosan solution. Consequently, we created a novel P24 sustained delivery system incorporated the Poly (lactic-co-glycolic acid) (PLGA) microspheres loaded P24 and n-HA microparticles into composite hydrogels. Then composite hydrogels were constructed, characterized, and tested for preosteoblastic (MC3T3-E1) in vitro. The osteoinductivity ability of composite hydrogel was tested by establishing an ectopic osteogenic model of the rat dorsal muscle pocket. After establishing the rat calvarial defect model, the bone defect was implanted the composite hydrogel with P24 microspheres to observe the ability of this composite system to repair the bone defect in vivo. Results The P24 peptides showed a sustained drug release profile over 60 days and markedly enhanced the efficiency in promoting the proliferation of cells and their expression of alkaline phosphatase (ALP). Additionally, the results of osteogenic gene expression and mineralization jointly confirmed that composite hydrogels could evoke a better cell osteodifferentiation viability in vitro. Through HE staining, Masson's trichrome staining and immunohistochemical staining, the results all above showed that the P24 microspheres composite hydrogel had a good osteoinductivity effect of ectopic osteogenic model in vivo. From the results of Micro CT, HE staining, Masson's trichrome staining and immunohistochemical staining in rat calvarial defect model, we knew that the composite hydrogel with P24-loaded microspheres composite hydrogel has a good ability to promote bone regeneration and is a potential bone tissue engineering material. Conclusion and Clinical Implications In this study, the osteogenic capability in vitro and regeneration capacity in vivo of a novel P24 sustained delivery system were investigated. The composite hydrogels enhanced the viability and osteogenic differentiation in vitro. In addition, the hydrogels had osteoinduction potential and promoted bone regeneration in vivo of rat ectopic bone formation and critical-sized calvarial defect model. In summary, the P24-hydrogel system construct could be a promising approach for bone regeneration.

Bone induction by biomimetic PLGA-(PEG-ASP)n copolymer loaded with a novel synthetic BMP-2-related peptide in vitro and in vivo

Bone induction by biomimetic PLGA copolymer loaded with a novel synthetic RADA16-P24 peptide in vivo.

A Polysaccharide-based Hydrogel and PLGA Microspheres for Sustained P24 Peptide Delivery: an in Vitro and in Vivo Study Based on Osteogenic Capability

A Polysaccharide‐based Composite Hydrogel Sustained Delivery P24 Peptide in PLGA Microsphere for Osteogenesis Potential in Vitro and in Vivo

Bone Induction Through Controlled Release of Novel Bmp-2-Related Peptide from Ptmc11-F127-Ptmc11 Hydrogels

Zero-order controlled release of BMP2-derived peptide P24 from the chitosan scaffold by chemical grafting modification technique for promotion of osteogenesis in vitro and enhancement of bone repair in vivo

Sustained Delivery of PlGF-2123-144*-fused BMP2-related Peptide P28 from Small Intestinal Submucosa/polylactic Acid Scaffold Material for Bone Tissue Regeneration

Ectopic bone formation in vivo induced by a novel synthetic peptide derived from BMP-2 using porous collagen scaffolds

Bone Morphogenetic Protein-2 Derived Peptide Loaded Calcium Sulfate Hemihydrate Scaffold for Enhanced Bone Tissue Regeneration

Sustained Delivery of BMP-2-Related Peptide from the True Bone Ceramics/Hollow Mesoporous Silica Nanoparticles Scaffold for Bone Tissue Regeneration

BMP-2 Immobilized PLGA/hydroxyapatite Fibrous Scaffold Via Polydopamine Stimulates Osteoblast Growth.

Preparation and characterization of oligopeptide modified PLGA-[ASP-PEG]biomimetic scaffolds

Improving Osteogenesis of PLGA/HA Porous Scaffolds Based on Dual Delivery of BMP-2 and IGF-1viaa Polydopamine Coating

Enhancement of Bone Formation by Bone Morphogenetic Protein-2 Released from Poly (L-Lactic-co-glycolic Acid) Microsphere

Osteoinductive Effects of Free and Immobilized Bone Forming Peptide-1 on Human Adipose-Derived Stem Cells.

Polydopamine-modified Poly(l-Lactic Acid) Nanofiber Scaffolds Immobilized with an Osteogenic Growth Peptide for Bone Tissue Regeneration.

Effects of Functionalization of Plga-[Asp-Peg]N Copolymer Surfaces with Arg-Gly-Asp Peptides, Hydroxyapatite Nanoparticles, and Bmp-2-Derived Peptides on Cell Behavior in Vitro

A biodegradable polymer as a cytokine delivery system for inducing bone formation

Enhanced Osteogenesis of Multilayered Pore-Closed Microsphere-Immobilized Hydroxyapatite Scaffold Via Sequential Delivery of Osteogenic Growth Peptide and BMP-2

Novel Osteogenic Growth Peptide C-terminal Pentapeptide Grafted Poly(d,l-Lactic Acid) Improves the Proliferation and Differentiation of Osteoblasts: the Potential Bone Regenerative Biomaterial.

Optimized Bone Regeneration Based on Sustained Release from Three‐dimensional Fibrous PLGA/HAp Composite Scaffolds Loaded with BMP‐2